Mara Aspinall 

Mara Aspinall was named executive chairman of the Lifeprint Group's board of directors. Aspinall currently is CEO of the consulting firm Health Catalysts. She was previously the president and CEO of Roche's Ventana Medical Systems and spent more than a decade at Genzyme, where she held various leadership roles, including president of Genzyme Genetics and Genzyme Pharmaceuticals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.